Galantamine Extended Release in Alzheimer's Disease: Profile Report

Author： Robinson Dean M.   Plosker Greg L.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.10, 2006-01, pp. : 839-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine Extended Release

By Robinson Dean M.   Plosker Greg L.  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 673-681

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Zolpidem Extended Release in Insomnia: Profile Report

By Moen Marit D.   Plosker Greg L.  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 843-846

Adis International

Access to resources Recommend Favorite

A Naturalistic Study of Galantamine for Alzheimer's Disease

By Brodaty Henry  

CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. : 935-943

Adis International

Access to resources Recommend Favorite

Galantamine Extended Release: A Viewpoint by Martin R. Farlow

By Farlow Martin R.  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 682-683

Adis International

Access to resources Recommend Favorite